Sign in

CIK 0001127537

  • Non-accelerated filer
  • Smaller reporting company

Pulmonx Corp

Sign in to watch
Ticker
LUNG
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 650-364-0400
Business address
700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
Former names
PULMONX
  1. 4 Open-market sale President and CEO sold 8,805 shares at $1.57 ($13,824)
  2. 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 6,322 shares at $1.57 ($9,926)
  3. 4 Grant or award COO and CFO acquired 1,200,000 shares (grant or award)
  4. 4 Open-market sale GENERAL COUNSEL sold 10,278 shares at $1.57 ($16,136)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market sale PRESIDENT AND CEO sold 9,648 shares at $1.60 ($15,437)
  7. 4 Open-market sale Chief Financial Officer & PAO sold 7,936 shares at $1.60 ($12,698)
  8. 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 6,543 shares at $1.60 ($10,469)
  9. 4 Open-market sale GENERAL COUNSEL sold 9,769 shares at $1.60 ($15,630)
  10. 4 Open-market sale Director sold 8,000 shares at $3.16 ($25,280)
  11. 4 Open-market buy Director bought 23,321 shares at $3.06 ($71,362)
  12. 4 Grant or award Director acquired 37,153 shares (grant or award)
  13. 4 Grant or award Director acquired 37,153 shares (grant or award)
  14. 4 Open-market sale PRESIDENT AND CEO sold 9,923 shares at $3.13 ($31,059)
  15. 4 Grant or award Director acquired 37,153 shares (grant or award)
  16. 4 Open-market sale Chief Financial Officer & PAO sold 8,061 shares at $3.13 ($25,231)
  17. 4 Grant or award Director acquired 37,153 shares (grant or award)
  18. 4 Grant or award Director acquired 37,153 shares (grant or award)
  19. 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 6,947 shares at an average $3.13 ($21,748)
  20. 4 Open-market sale GENERAL COUNSEL sold 10,457 shares at an average $3.13 ($32,736)

Page 2 of 12 · 229 filings